SYMPTOMATIC HYPOCALCAEMIA AFTER TREATMENT WITH HIGH-DOSE AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE

The Lancet

Volumn 329, Issue 8533, 1987, Pages 622-

  Jodrell, DuncanI ^a   Iveson, TimJ ^a   Smith, IanE ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; GLUCONATE CALCIUM; MITHRAMYCIN; PAMIDRONIC ACID;

ADVERSE DRUG REACTION; BONE; BONE METASTASIS; BREAST; BREAST CANCER; BREAST CARCINOMA; CASE REPORT; DRUG THERAPY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PRIORITY JOURNAL; THERAPY;

CASE REPORT; DIPHOSPHONATES; FEMALE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; MIDDLE AGE;

EID: 0023150031     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)90255-8     Document Type: Letter

References (3)

1. Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-biphosphonate and volume repletion in tumour-induced hypercalcaemia
2. Single high dose aminohydroxypropylidene diphosphonate infusions to treat breast cancer associated hypercalcaemia
3. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia